Gilead Sciences | GILD - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q3 Sep/2025 2.23 2.47 Oct/22
FY2026Q2 Jun/2026 -6.75 -7.32 2.01 Aug/04
FY2026Q1 Mar/2026 2.03 1.9 1.81 May/07
FY2025Q4 Dec/2025 1.86 1.89 1.90 Feb/10
FY2025Q3 Sep/2025 2.47 2.16 2.02 Oct/30




Eps تغيير تاريخ
AbbVie USD 3.65 1 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
ALKERMES USD 0 0.4 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 8.38 0.17 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
Glaxosmithkline GBP 0.62 0.41 2026-03
Incyte USD 3.09 1.28 2026-06
J&J USD 2.9 0.2 2026-06
Merck USD -0.13 1.15 2026-06
Moderna USD -1.97 1.43 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 2.41 0.42 2026-06
Pfizer USD 0.77 0.02 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.09 0.21 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
United Therapeutics USD 7.27 1.45 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06